IN8bio (INAB)
(Delayed Data from NSDQ)
$1.04 USD
-0.02 (-1.89%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.02 -0.02 (-1.92%) 7:42 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/10/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | -31.25% |
ABR | 1.00 |
Earnings ESP
|
9.09% |
---|---|
Current Year | -0.64 |
Next Year | -0.51 |
EPS (TTM) | -1.01 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 27.60M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 27.60M |
Low Estimate | NA | NA | NA | 27.60M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.17 | -0.64 | -0.51 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.15 | -0.15 | -0.58 | -0.59 |
High Estimate | -0.15 | -0.15 | -0.58 | -0.42 |
Low Estimate | -0.18 | -0.19 | -0.70 | -0.59 |
Year ago EPS | -0.30 | -0.27 | -1.00 | -0.64 |
Year over Year Growth Est. | 43.33% | 37.04% | 36.00% | 21.09% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.17 | -0.64 | -0.51 |
7 Days Ago | -0.18 | -0.19 | -0.70 | -0.42 |
30 Days Ago | -0.18 | -0.19 | -0.70 | -0.42 |
60 Days Ago | -0.18 | -0.20 | -0.79 | -0.65 |
90 Days Ago | -0.18 | -0.20 | -0.79 | -0.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.15 | -0.15 | -0.58 | -0.59 |
Zacks Consensus Estimate | -0.17 | -0.17 | -0.64 | -0.51 |
Earnings ESP | 9.09% | 11.77% | 9.38% | -16.83% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | -0.23 | -0.27 | -0.30 | NA |
Estimate | -0.16 | -0.25 | -0.28 | -0.33 | NA |
Difference | -0.05 | 0.02 | 0.01 | 0.03 | 0.00 |
Surprise | -31.25% | 8.00% | 3.57% | 9.09% | -2.65% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more